OC-0438 Proton-therapy and concurrent chemotherapy in stage III NSCLC: effects on hematological toxicity. (May 2022) - Cortiula, F.; Hendriks, L.; Steens, M.; Dursun, S.; Bootsma, G.; Canters, R.; Rinaldi, I.; Taasti, V.T.; Houben, R.; Reynders, K.; Peeters, S.; Angrisani, A.; et al.